This important study will allow for a better understanding of anthelmintic drug resistance in nematodes, a growing concern for public health. The authors provide a detailed analysis of the role of UBR ...

A panelist discusses how glucagon-like peptide-1 receptor (GLP-1) agonists' cardioprotective effects likely stem from multiple physiological mechanisms, including reduced inflammation, improved ...

With so many weight loss medications on the market, it's easy to feel overwhelmed by the options. From brand-name heavy ...

The term "nonalcoholic fatty liver disease" (NAFLD) has long been used to describe liver steatosis not related to excessive alcohol consumption ...

GLP-1 receptor agonists have gained popularity due to their dual benefits in managing Type-II diabetes and promoting ...

Scientists uncover how TRH neurons suppress hunger by inhibiting AgRP neurons, advancing our understanding of GLP-1-based ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with ...

GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential ...

Two new studies identified additional benefits of medications like semaglutide—the active ingredient in Novo Nordisk's ...

By illuminating how diet and other lifestyle factors may affect a person's likelihood of developing a blood disorder as well as disease progression and response to treatment, the studies point to ...

Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising ...

An open-label Phase III trial showed that participants using Zepbound saw 47% greater relative weight loss compared to Wegovy.